The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care
-
Published:2023-01-04
Issue:2
Volume:128
Page:161-164
-
ISSN:0007-0920
-
Container-title:British Journal of Cancer
-
language:en
-
Short-container-title:Br J Cancer
Author:
Cerone Maria Antonietta, Mills Tara C., Sharpe Rowena, McBride David, MacDonald Moira, MacMahon Suzanne, Mugalaasi Hood, Rehal Pauline, Rettino Alessandro, Roberts Helen, Ross Mark, White Donald Edward, Peden John, Rawlinson Janette, Ho Steffan N., Hollingsworth Simon, Popat SanjayORCID, Middleton GaryORCID, Johnson Peter, Swanton CharlesORCID, Man Somai, Butler Rachel, White Rhian, Morgan Sian, Wood Sian, Thompson Lisa, Carr Hedley, Subramaniam Sumi, McGuire Cian, Pitman Helen, Chen Isabella, Tunna Kirsty, Rehman Sahar, Middleton Catrin, Alvi Abdullah,
Abstract
SummaryGenomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference6 articles.
1. Hiley CT, Le Quesne J, Santis G, Sharpe R, de Castro DG, Middleton G, et al. Challenges in molecular testing in non-small-cell lung cancer patients with advanced diseases. Lancet. 2016;388:1002–112016. 2. Middleton G, Fletcher P, Popat S, Savage J, Summers Y, Greystoke A, et al. The National Lung Matrix Trial of personalised therapy in lung cancer. Nature. 2020;583:807–12. 3. Flaherty KT, Gray R, Chen A, Li S, Patton D, Hamilton SR, et al. The Molecular Analysis for Therapy Choice (NCI-MATCH) trial: lessons for genomic trial design. J Natl Cancer Inst. 2020;112:1021–9. 4. Murciano-Goroff YR, Drilon A, Stadler ZK. The NCI-MATCH: a national, collaborative precision oncology trial for diverse tumour histologies. Cancer Cell. 2021;39:22–24. 5. Redman MW, Papadimitrakopoulou VA, Minichiello K, Hirsch FR, Mack PC, Schwarts LH, et al. Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol. Lancet Oncol. 2020;21:1589–602.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|